These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2137563)

  • 41. Ondansetron inhibits the analgesic effects of tramadol: a possible 5-HT(3) spinal receptor involvement in acute pain in humans.
    Arcioni R; della Rocca M; Romanò S; Romano R; Pietropaoli P; Gasparetto A
    Anesth Analg; 2002 Jun; 94(6):1553-7, table of contents. PubMed ID: 12032025
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.
    Molderings GJ; Schmidt K; Bönisch H; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):245-52. PubMed ID: 8878053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-HT3 receptors and the therapeutic potential of 5-HT3 receptor antagonists.
    Tyers MB
    Therapie; 1991; 46(6):431-5. PubMed ID: 1840227
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbens.
    Chen JP; van Praag HM; Gardner EL
    Brain Res; 1991 Mar; 543(2):354-7. PubMed ID: 1711914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. BRL 46470A: a highly potent, selective and long acting 5-HT3 receptor antagonist with anxiolytic-like properties.
    Blackburn TP; Baxter GS; Kennett GA; King FD; Piper DC; Sanger GJ; Thomas DR; Upton N; Wood MD
    Psychopharmacology (Berl); 1993; 110(3):257-64. PubMed ID: 7831418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of emesis in patients receiving cytotoxic drugs by GR38032F, a selective 5-HT3 receptor antagonist.
    Cunningham D; Hawthorn J; Pople A; Gazet JC; Ford HT; Challoner T; Coombes RC
    Lancet; 1987 Jun; 1(8548):1461-3. PubMed ID: 2885454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological characterization of 5-hydroxytryptamine-induced apnea in the rat.
    Yoshioka M; Goda Y; Togashi H; Matsumoto M; Saito H
    J Pharmacol Exp Ther; 1992 Feb; 260(2):917-24. PubMed ID: 1531363
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of afferent-evoked neurotransmission by 5-HT3 receptors in young rat dorsal horn neurones in vitro: a putative mechanism of 5-HT3 induced anti-nociception.
    Khasabov SG; Lopez-Garcia JA; Asghar AU; King AE
    Br J Pharmacol; 1999 Jun; 127(4):843-52. PubMed ID: 10433490
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-Hydroxytryptamine3 receptors mediate tachycardia in conscious instrumented dogs.
    Wilson H; Coffman WJ; Cohen ML
    J Pharmacol Exp Ther; 1990 Feb; 252(2):683-8. PubMed ID: 1968974
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The 5HT3 receptors and the descending nociceptive pathway--a review.
    Gupta S; Vaswani R; Verma D
    Middle East J Anaesthesiol; 1999 Oct; 15(3):247-58. PubMed ID: 10932685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Ondansetron--the first highly selective 5-HT3 antagonist in therapy of psychiatric diseases].
    Broocks A
    Fortschr Neurol Psychiatr; 1992 Jun; 60(6):227-36. PubMed ID: 1386589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological properties and functions of central 5-HT3 receptors.
    Costall B; Naylor RJ
    Therapie; 1991; 46(6):437-44. PubMed ID: 1840228
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 8-OH-DPAT specifically enhances feeding behaviour in mice: evidence from behavioural competition.
    Shepherd JK; Rodgers RJ
    Psychopharmacology (Berl); 1990; 101(3):408-13. PubMed ID: 2141947
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Social conflict analgesia: inhibition of early non-opioid component by diazepam or flumazepil fails to affect appearance of late opioid component.
    Rodgers RJ; Randall JI
    Brain Res Bull; 1987 Jul; 19(1):141-4. PubMed ID: 3115496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam.
    Nunes-de-Souza RL; Canto-de-Souza A; da-Costa M; Fornari RV; Graeff FG; Pelá IR
    Psychopharmacology (Berl); 2000 Jun; 150(3):300-10. PubMed ID: 10923758
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations.
    Lee C; Rodgers RJ
    Psychopharmacology (Berl); 1990; 102(4):507-13. PubMed ID: 1965750
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ondansetron does not block tramadol-induced analgesia in mice.
    Erhan E; Onal A; Kocabas S; Parlar A; Yegul I; Kosay S
    Methods Find Exp Clin Pharmacol; 2005 Nov; 27(9):629-32. PubMed ID: 16357947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The 5HT3 antagonist GR38032F is highly toxic in DBA/2 mice.
    Hendrie CA
    Psychopharmacology (Berl); 1990; 101(3):429-30. PubMed ID: 2141948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.